These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 17952155)

  • 1. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M; Moum B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():24-30. PubMed ID: 15352890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and surveillance of ulcerative colitis.
    Axon AT
    Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):129-45. PubMed ID: 8995118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will a 5-ASA a day keep the cancer (and dysplasia) away?
    Rubin DT; Lashner BA
    Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Jewell D
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
    Mouzas IA; Papavassiliou E; Koutroubakis I
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colitis cancer--myth or reality?].
    Hertervig E; Befrits R; Ekbom A; Karlén P; Lindberg J; Löfberg R; Rutegård J; Sjöqvist U; Ost A
    Lakartidningen; 2009 Nov 4-12; 106(45):3000-2. PubMed ID: 19998826
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.